Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Insulin-like growth factor axis in pregnancy and gestational diabetes mellitus.

Anderlová K, Cinkajzlová A, Šimják P, Kloučková J, Kratochvílová H, Lacinová Z, Kaválková P, Krejčí H, Mráz M, Pařízek A, Haluzík M, Kršek M.

Physiol Res. 2019 Aug 19. [Epub ahead of print]

2.

Increased intestinal permeability in patients with short bowel syndrome is not affected by parenteral nutrition.

Cinkajzlová A, Lacinová Z, Kloučková J, Kaválková P, Kratochvílová H, Křížová J, Trachta P, Mráz M, Haluzík M.

Physiol Res. 2019 Aug 19. [Epub ahead of print]

3.

The effect of dicarbonyl stress on the development of kidney dysfunction in metabolic syndrome - a transcriptomic and proteomic approach.

Markova I, Hüttl M, Oliyarnyk O, Kacerova T, Haluzik M, Kacer P, Seda O, Malinska H.

Nutr Metab (Lond). 2019 Aug 1;16:51. doi: 10.1186/s12986-019-0376-1. eCollection 2019.

4.

The number and phenotype of myocardial and adipose tissue CD68+ cells is associated with cardiovascular and metabolic disease in heart surgery patients.

Pierzynová A, Šrámek J, Cinkajzlová A, Kratochvílová H, Lindner J, Haluzík M, Kučera T.

Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):946-955. doi: 10.1016/j.numecd.2019.05.063. Epub 2019 May 30.

PMID:
31307852
5.

Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease.

Mráz M, Cinkajzlová A, Kloučková J, Lacinová Z, Kratochvílová H, Lipš M, Pořízka M, Kopecký P, Lindner J, Kotulák T, Netuka I, Haluzík M.

Mediators Inflamm. 2019 May 9;2019:5481725. doi: 10.1155/2019/5481725. eCollection 2019.

6.

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.

Aroda VR, González-Galvez G, Grøn R, Halladin N, Haluzík M, Jermendy G, Kok A, Őrsy P, Sabbah M, Sesti G, Silver R.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):596-605. doi: 10.1016/S2213-8587(19)30184-6. Epub 2019 Jun 9.

PMID:
31189519
7.

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

Aroda VR, Rosenstock J, Terauchi Y, Altuntas Y, Lalic NM, Morales Villegas EC, Jeppesen OK, Christiansen E, Hertz CL, Haluzík M; PIONEER 1 Investigators.

Diabetes Care. 2019 Sep;42(9):1724-1732. doi: 10.2337/dc19-0749. Epub 2019 Jun 11.

PMID:
31186300
8.

Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions.

Kratochvilova H, Lacinova Z, Klouckova J, Kavalkova P, Cinkajzlova A, Trachta P, Krizova J, Benes M, Dolezalova K, Fried M, Vlasakova Z, Pelikanova T, Spicak J, Mraz M, Haluzik M.

Diabetes Metab Syndr Obes. 2019 Mar 28;12:423-430. doi: 10.2147/DMSO.S193259. eCollection 2019.

9.

Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth.

Svoboda P, Krizova E, Sestakova S, Vapenkova K, Knejzlik Z, Rimpelova S, Rayova D, Volfova N, Krizova I, Rumlova M, Sykora D, Kizek R, Haluzik M, Zidek V, Zidkova J, Skop V.

J Biol Chem. 2019 May 31;294(22):8676-8689. doi: 10.1074/jbc.RA118.003505. Epub 2019 Apr 11.

PMID:
30975903
10.

FGF21 Levels in Pheochromocytoma/Functional Paraganglioma.

Klímová J, Zelinka T, Rosa J, Štrauch B, Haluzíková D, Haluzík M, Holaj R, Krátká Z, Kvasnička J, Ďurovcová V, Matoulek M, Novák K, Michalský D, Widimský J Jr, Petrák O.

Cancers (Basel). 2019 Apr 5;11(4). pii: E485. doi: 10.3390/cancers11040485.

11.

Bariatric/metabolic surgery: the diabetologists view.

Haluzík M.

Rozhl Chir. Winter 2019;98(2):46-51. Review.

PMID:
30897911
12.

Minor lipids profiling in subcutaneous and epicardial fat tissue using LC/MS with an optimized preanalytical phase.

Tomášová P, Čermáková M, Pelantová H, Vecka M, Kratochvílová H, Lipš M, Lindner J, Šedivá B, Haluzík M, Kuzma M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Apr 15;1113:50-59. doi: 10.1016/j.jchromb.2019.03.006. Epub 2019 Mar 12.

PMID:
30897405
13.

Coronary Artery Disease Is Associated with an Increased Amount of T Lymphocytes in Human Epicardial Adipose Tissue.

Mráz M, Cinkajzlová A, Kloučková J, Lacinová Z, Kratochvílová H, Lipš M, Pořízka M, Kopecký P, Pierzynová A, Kučera T, Melenovský V, Stříž I, Lindner J, Haluzík M.

Mediators Inflamm. 2019 Feb 7;2019:4075086. doi: 10.1155/2019/4075086. eCollection 2019.

14.

A Plant-Based Meal Stimulates Incretin and Insulin Secretion More Than an Energy- and Macronutrient-Matched Standard Meal in Type 2 Diabetes: A Randomized Crossover Study.

Kahleova H, Tura A, Klementova M, Thieme L, Haluzik M, Pavlovicova R, Hill M, Pelikanova T.

Nutrients. 2019 Feb 26;11(3). pii: E486. doi: 10.3390/nu11030486.

15.

A Plant-Based Meal Increases Gastrointestinal Hormones and Satiety More Than an Energy- and Macronutrient-Matched Processed-Meat Meal in T2D, Obese, and Healthy Men: A Three-Group Randomized Crossover Study.

Klementova M, Thieme L, Haluzik M, Pavlovicova R, Hill M, Pelikanova T, Kahleova H.

Nutrients. 2019 Jan 12;11(1). pii: E157. doi: 10.3390/nu11010157.

16.

Changes in plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus.

Šimják P, Cinkajzlová A, Anderlová K, Kloučková J, Kratochvílová H, Lacinová Z, Kaválková P, Krejčí H, Mráz M, Pařízek A, Kršek M, Haluzík M.

Physiol Res. 2018 Nov 28;67(Supplementum 3):S531-S542.

17.

Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.

Holubová M, Hrubá L, Popelová A, Bencze M, Pražienková V, Gengler S, Kratochvílová H, Haluzík M, Železná B, Kuneš J, Hölscher C, Maletínská L.

Neuropharmacology. 2019 Jan;144:377-387. doi: 10.1016/j.neuropharm.2018.11.002. Epub 2018 Nov 11.

PMID:
30428311
18.

Visceral fat and insulin resistance - what we know?

Janochova K, Haluzik M, Buzga M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Feb;163(1):19-27. doi: 10.5507/bp.2018.062. Epub 2018 Nov 6. Review.

19.

Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination.

Tomášová P, Bugáňová M, Pelantová H, Holubová M, Šedivá B, Železná B, Haluzík M, Maletínská L, Kuneš J, Kuzma M.

Appl Biochem Biotechnol. 2019 May;188(1):165-184. doi: 10.1007/s12010-018-2899-8. Epub 2018 Nov 5.

PMID:
30393821
20.

Changes in omentin levels and its mRNA expression in epicardial adipose tissue in patients undergoing elective cardiac surgery: the influence of type 2 diabetes and coronary heart disease.

Matloch Z, Kratochvílová H, Cinkajzlová A, Lipš M, Kopecký P, Pořízka M, Haluzíková D, Lindner J, Mráz M, Kloučková J, Lacinová Z, Haluzík M.

Physiol Res. 2018 Dec 18;67(6):881-890. Epub 2018 Sep 11.

21.

Intermittent Fasting and Prevention of Diabetic Retinopathy: Where Do We Go From Here?

Haluzík M, Mráz M.

Diabetes. 2018 Sep;67(9):1745-1747. doi: 10.2337/dbi18-0022. No abstract available.

22.

Endothelial Microvesicles and Soluble Markers of Endothelial Injury in Critically Ill Newborns.

Vítková V, Pánek M, Janec P, Šibíková M, Vobruba V, Haluzík M, Živný J, Janota J.

Mediators Inflamm. 2018 Jul 19;2018:1975056. doi: 10.1155/2018/1975056. eCollection 2018.

23.
24.

The role of obesity and adipose tissue dysfunction in gestational diabetes mellitus.

Šimják P, Cinkajzlová A, Anderlová K, Pařízek A, Mráz M, Kršek M, Haluzík M.

J Endocrinol. 2018 Aug;238(2):R63-R77. doi: 10.1530/JOE-18-0032. Epub 2018 May 9. Review.

PMID:
29743342
25.

Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation.

Cinkajzlová A, Mráz M, Lacinová Z, Kloučková J, Kaválková P, Kratochvílová H, Trachta P, Křížová J, Haluzíková D, Škrha J, Papežová H, Haluzík M.

Nutr Diabetes. 2018 Apr 25;8(1):21. doi: 10.1038/s41387-018-0032-2.

26.

Circadian leptin concentration changes in critically ill heart failure patients.

Cundrle I Jr, Suk P, Sramek V, Lacinova Z, Haluzik M.

Physiol Res. 2018 Jul 17;67(3):505-508. Epub 2018 Mar 12.

27.

Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries.

Haluzik M, Kretowski A, Strojek K, Czupryniak L, Janez A, Kempler P, Andel M, Tankova T, Boyanov M, Smircic Duvnjak L, Madacsy L, Tarnowska I, Zychma M, Lalic N.

Diabetes Ther. 2018 Apr;9(2):727-741. doi: 10.1007/s13300-018-0388-2. Epub 2018 Mar 9.

29.

Gut as an emerging organ for the treatment of diabetes: focus on mechanism of action of bariatric and endoscopic interventions.

Haluzík M, Kratochvílová H, Haluzíková D, Mráz M.

J Endocrinol. 2018 Apr;237(1):R1-R17. doi: 10.1530/JOE-17-0438. Epub 2018 Jan 29. Review.

PMID:
29378901
30.

Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.

Mikulášková B, Holubová M, Pražienková V, Zemenová J, Hrubá L, Haluzík M, Železná B, Kuneš J, Maletínská L.

Nutr Diabetes. 2018 Jan 16;8(1):5. doi: 10.1038/s41387-017-0015-8.

31.

The Role of Inflammation in Epicardial Adipose Tissue in Heart Diseases.

Matloch Z, Cinkajzlova A, Mraz M, Haluzik M.

Curr Pharm Des. 2018;24(3):297-309. doi: 10.2174/1381612824666180110102125. Review.

PMID:
29318960
32.

Pitfalls in screening for gestational diabetes in the Czech Republic - patient survey.

Šimják P, Anderlová K, Krejčí H, Krejčí V, Pařízková P, Mráz M, Kršek M, Haluzík M, Pařízek A.

Ceska Gynekol. Winter 2018;83(5):348-353.

PMID:
30848138
33.

A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway.

Fried M, Dolezalova K, Chambers AP, Fegelman EJ, Scamuffa R, Schwiers ML, Waggoner JR, Haluzik M, Seeley RJ.

BMJ Open Diabetes Res Care. 2017 Sep 1;5(1):e000431. doi: 10.1136/bmjdrc-2017-000431. eCollection 2017.

34.

Metformin attenuates myocardium dicarbonyl stress induced by chronic hypertriglyceridemia.

Malinska H, Škop V, Trnovska J, Markova I, Svoboda P, Kazdova L, Haluzik M.

Physiol Res. 2018 May 4;67(2):181-189. Epub 2017 Nov 10.

35.

Specific metabolic characteristics of women with former gestational diabetes: the importance of adipose tissue.

Vejrazkova D, Vankova M, Lukasova P, Vcelak J, Cirmanova V, Haluzik M, Bendlova B.

Physiol Res. 2017 Sep 26;66(Supplementum 3):S349-S356. Review.

36.

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity.

Pražienková V, Holubová M, Pelantová H, Bugáňová M, Pirník Z, Mikulášková B, Popelová A, Blechová M, Haluzík M, Železná B, Kuzma M, Kuneš J, Maletínská L.

PLoS One. 2017 Aug 18;12(8):e0183449. doi: 10.1371/journal.pone.0183449. eCollection 2017.

37.

The effect of very-low-calorie diet on mitochondrial dysfunction in subcutaneous adipose tissue and peripheral monocytes of obese subjects with type 2 diabetes mellitus.

Urbanová M, Mráz M, Ďurovcová V, Trachta P, Kloučková J, Kaválková P, Haluzíková D, Lacinová Z, Hansíková H, Wenchich L, Kršek M, Haluzík M.

Physiol Res. 2017 Nov 24;66(5):811-822. Epub 2017 Jul 18.

38.

Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls.

Trnovská J, Šilhavý J, Kuda O, Landa V, Zídek V, Mlejnek P, Šimáková M, Strnad H, Škop V, Oliyarnyk O, Kazdová L, Haluzík M, Pravenec M.

PLoS One. 2017 Jun 6;12(6):e0179063. doi: 10.1371/journal.pone.0179063. eCollection 2017.

39.

Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: A single-blind, randomized controlled trial.

Lipš M, Mráz M, Kloučková J, Kopecký P, Dobiáš M, Křížová J, Lindner J, Diamant M, Haluzík M.

Diabetes Obes Metab. 2017 Dec;19(12):1818-1822. doi: 10.1111/dom.13029. Epub 2017 Jul 31.

PMID:
28581209
40.

An alternatively activated macrophage marker CD163 in severely obese patients: the influence of very low-calorie diet and bariatric surgery.

Cinkajzlová A, Lacinová Z, Kloučková J, Kaválková P, Trachta P, Kosák M, Krátký J, Kasalický M, DoleŽalová K, Mráz M, Haluzík M.

Physiol Res. 2017 Sep 22;66(4):641-652. Epub 2017 Apr 12.

41.
42.

Comparison of Plasma Osteopontin Levels between Patients with Borderline Ovarian Tumours and Serous Ovarian Carcinoma.

Živný JH, Leahomschi S, Klener P Jr, Živný J, Haluzík M, Cibula D.

Folia Biol (Praha). 2016;62(6):258-262.

43.

Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?

Cinkajzlová A, Mráz M, Haluzík M.

Protoplasma. 2017 May;254(3):1219-1232. doi: 10.1007/s00709-017-1082-3. Epub 2017 Feb 1. Review.

PMID:
28150048
44.

The effects of liraglutide in mice with diet-induced obesity studied by metabolomics.

Bugáňová M, Pelantová H, Holubová M, Šedivá B, Maletínská L, Železná B, Kuneš J, Kačer P, Kuzma M, Haluzík M.

J Endocrinol. 2017 Apr;233(1):93-104. doi: 10.1530/JOE-16-0478. Epub 2017 Jan 30.

PMID:
28138003
45.

Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study.

Piecha R, Svačina Š, Malý M, Vrbík K, Lacinová Z, Haluzík M, Pavloušková J, Vavrouš A, Matějková D, Müllerová D, Mráz M, Matoulek M.

Cent Eur J Public Health. 2016 Dec;24(4):297-301. doi: 10.21101/cejph.a4704.

46.

[Bariatric surgeries at diabetic patients].

Haluzík M.

Vnitr Lek. 2016 Fall;62(11 Suppl 4):S30-35. Review. Czech.

PMID:
27921423
47.

Metabolically healthy obese individuals -- mechanisms and clinical relevance.

Hrasko T, Bendlová B, Hainer V, Haluzík M.

Cesk Fysiol. 2016 Oct;65(1):38-46. Review. English, Czech.

PMID:
29489091
48.

Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration.

Zelenka J, Dvořák A, Alán L, Zadinová M, Haluzík M, Vítek L.

Oxid Med Cell Longev. 2016;2016:6190609. doi: 10.1155/2016/6190609. Epub 2016 Jul 31.

49.

Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.

Kaválková P, Mráz M, Trachta P, Kloučková J, Cinkajzlová A, Lacinová Z, Haluzíková D, Beneš M, Vlasáková Z, Burda V, Novák D, Petr T, Vítek L, Pelikánová T, Haluzík M.

J Endocrinol. 2016 Oct;231(1):11-22. doi: 10.1530/JOE-16-0206. Epub 2016 Jul 29.

PMID:
27474690
50.

Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination.

Pelantová H, Bugáňová M, Holubová M, Šedivá B, Zemenová J, Sýkora D, Kaválková P, Haluzík M, Železná B, Maletínská L, Kuneš J, Kuzma M.

Mol Cell Endocrinol. 2016 Aug 15;431:88-100. doi: 10.1016/j.mce.2016.05.003. Epub 2016 May 7.

PMID:
27164444

Supplemental Content

Loading ...
Support Center